DFX Intelligence
Borrowers
1,057 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Start from
1,057 borrower groups match
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| Nephron Pharmaceuticals, LLC Life sciences | unattributed | 4 | at least $17.2M | 98c | 5 pts | Dec 30, 2027 | Sep 30, 2023 |
| Onward Medical Life sciences | unattributed | 1 | at least $17.1M | 104c | n/a | Jun 15, 2028 | Jun 30, 2024 |
| ADC Therapeutics SA Life sciences | unattributed | 2 | at least $17.0M | 102c | 0 pts | Aug 15, 2029 | Sep 30, 2022 |
| A••••••• B••••• L•• Healthcare services | unattributed | 2 | at least $17.0M | 100c | n/a | Jan 30, 2033 | Mar 31, 2026 |
| H••••• B•••• G•••••• G••• Life sciences | unattributed | 2 | at least $16.9M | 98c | 0 pts | Apr 29, 2033 | Jun 30, 2026 |
| B••••••••• Life sciences | unattributed | 1 | at least $16.8M | 88c | n/a | Dec 31, 2028 | Dec 31, 2022 |
| E•••• C••• O••• L•• Healthcare services | unattributed | 3 | at least $16.7M | 100c | 0 pts | Jul 31, 2030 | Sep 30, 2025 |
| S••••••••• I•• Education | Sponsor not establishedpossible: 1••• C•••••• (a company of this name is on the sponsor's portfolio page) | 2 | at least $16.3M | 100c | n/a | Nov 19, 2031 | Dec 31, 2025 |
| O•• L•• O•••• B••••• L•• Life sciences | unattributed | 2 | at least $16.3M | 92c | 0 pts | Jul 18, 2030 | Sep 30, 2024 |
| N••• M••••••••• S••••••• C••••••••• Healthcare services | unattributed | 5 | at least $16.0M | 72c | 2 pts | Feb 23, 2029 | Dec 31, 2021 |
| M••• H•••••• C• Healthcare services | unattributed | 3 | at least $16.0M | 101c | 1 pts | Dec 23, 2030 | Dec 31, 2024 |
| D••• S••••• Life sciences | Q••••• M••••••••• I••• inferred | 5 | at least $15.8M | 100c | 0 pts | Mar 24, 2033 | Dec 31, 2025 |
| W•• G•••• H•••••••• L•• Life sciences | unattributed | 2 | at least $15.7M | 101c | 0 pts | Dec 31, 2029 | Dec 31, 2023 |
| T•• C••••• f•• O••••••••• a•• R••••••• E••••••••• I•• Healthcare services | unattributed | 4 | at least $15.5M | 100c | n/a | Jun 30, 2028 | Dec 31, 2022 |
| S••••• U• B•••• C••• Life sciences · grade B | unattributed | 1 | at least $15.5M | 105c | n/a | Jul 31, 2029 | Dec 31, 2022 |
| B• E•• B••••• I•• Healthcare services | unattributed | 2 | at least $15.5M | 101c | n/a | Nov 23, 2027 | Dec 31, 2022 |
| D•••••••• I•• Life sciences | unattributed | 4 | at least $15.4M | 100c | 0 pts | Dec 18, 2029 | Dec 31, 2022 |
| A••••• B•• A••••• B••••••••• L•• Life sciences | unattributed | 1 | at least $15.3M | 96c | n/a | Jun 1, 2029 | Jun 30, 2024 |
| P••••• H••••• I••••••••• H••••••• I••• A•• C••• P•• Financial services | unattributed | 1 | at least $15.2M | 100c | n/a | Jun 1, 2030 | Dec 31, 2024 |
| 4• M•••••••• T••••••••• I•• Life sciences | Sponsor not establishedpossible: V••••• G••••• I•••••••• L• (a company of this name is on the sponsor's portfolio page) | 1 | at least $15.2M | 100c | n/a | Jun 1, 2031 | Dec 31, 2025 |
| B••••• B••••••••• H••••••• L•• Life sciences | unattributed | 4 | at least $15.1M | 100c | n/a | Jun 21, 2029 | Dec 31, 2024 |
| C•••••• I•••••• A••••••••• C••• Healthcare services | unattributed | 3 | at least $15.1M | 101c | n/a | Jan 3, 2030 | Dec 31, 2022 |
| A•••••• T••••••••• I•• Life sciences | unattributed | 1 | at least $15.0M | 100c | n/a | Apr 1, 2026 | Dec 31, 2022 |
| C•••••••• I••••••••• H•••••• L•• Healthcare services | Sponsor not establishedpossible: S••••••• S••••• C•••••• P••••••• (a company of this name is on the sponsor's portfolio page) | 1 | at least $15.0M | 100c | n/a | Jun 1, 2030 | Jun 30, 2026 |
| H••••••••• G• M•••••• T••••••••• I•• Healthcare services | unattributed | 1 | at least $15.0M | 100c | n/a | Oct 1, 2029 | Dec 31, 2024 |
| O•••••••• B••••• H•••••••• I•• Life sciences | unattributed | 1 | at least $15.0M | 101c | n/a | Nov 1, 2028 | Dec 31, 2024 |
| C•• T• M••••• S••• L•• Life sciences | unattributed | 1 | at least $15.0M | 100c | n/a | May 31, 2029 | Jun 30, 2023 |
| C••••• B•••• S•••••• Life sciences | unattributed | 7 | at least $14.9M | 100c | 1 pts | Aug 1, 2031 | Sep 30, 2022 |
| A•••• H••••••••• L•• Healthcare services | unattributed | 2 | at least $14.8M | 100c | 0 pts | May 13, 2032 | Jun 30, 2026 |
| S•••••• H••••• H•••••••• L•• Healthcare services | unattributed | 3 | at least $14.7M | 27c | n/a | Jun 3, 2026 | Jun 30, 2024 |
| E••• I••••••••• I• L•• Life sciences | unattributed | 2 | at least $14.7M | 101c | n/a | Sep 26, 2031 | Sep 30, 2025 |
| A•••••• P•••••• I•• Healthcare services | unattributed | 2 | at least $14.6M | 73c | 8 pts | Mar 31, 2029 | Dec 31, 2022 |
| V•• M••• L•• Healthcare services | unattributed | 1 | at least $14.6M | 102c | n/a | Dec 18, 2030 | Dec 31, 2025 |
| V•• S•••• O••• L•• Healthcare services | unattributed | 3 | at least $14.6M | 102c | n/a | Jun 14, 2028 | Jun 30, 2023 |
| V••••• B•••• L•••••• Life sciences | unattributed | 2 | at least $14.5M | 99c | 0 pts | Aug 20, 2030 | Sep 30, 2025 |
| A•••• B•••• Life sciences · grade B | unattributed | 1 | at least $14.5M | 98c | n/a | Oct 29, 2032 | Jun 30, 2025 |
| S••••••• P•••• S•••••• B•••• L•• Life sciences | unattributed | 1 | at least $14.5M | 97c | n/a | Sep 24, 2031 | Dec 31, 2025 |
| S••••• B•••• I• I••• I•••••• U••• D••••• Life sciences | unattributed | 1 | at least $14.4M | 100c | n/a | Feb 2, 2032 | Mar 31, 2025 |
| B•••• S•••• Life sciences | unattributed | 3 | at least $14.4M | 103c | 6 pts | Jun 30, 2031 | Sep 30, 2024 |
| C•••• L••••••• L•• Healthcare services | unattributed | 2 | at least $14.4M | 100c | 0 pts | May 28, 2031 | Dec 31, 2024 |
| S••••• O•••• Life sciences | Sponsor not establishedpossible: I••••••• C•••••• P•••••••• L•• (a company of this name is on the sponsor's portfolio page) | 2 | at least $14.3M | 101c | 0 pts | Jul 31, 2028 | Dec 31, 2024 |
| E•••• B••••• L•• Life sciences | unattributed | 2 | at least $14.1M | 99c | 0 pts | Mar 12, 2033 | Mar 31, 2026 |
| L••• S•••••• K•• T••••••••• I•• Life sciences | unattributed | 1 | at least $14.0M | 100c | n/a | Apr 1, 2030 | Dec 31, 2024 |
| S••••• S•••• • J•••• C•••••• Healthcare services · Life sciences | M••••• E••••• P•••••••• L•• inferred | 1 | at least $14.0M | 102c | n/a | Mar 25, 2031 | Dec 31, 2024 |
| B•••••• T••••••••• I•• Life sciences | unattributed | 2 | at least $14.0M | 88c | 0 pts | Apr 19, 2027 | Sep 30, 2022 |
| A•••• M•••••• P•••••••• L•• Life sciences | unattributed | 4 | at least $14.0M | 100c | 1 pts | Jun 10, 2028 | Sep 30, 2021 |
| C••••••••• H•••••••• I•• Life sciences | unattributed | 4 | at least $14.0M | 100c | n/a | Oct 31, 2028 | Dec 31, 2023 |
| B••••••••• I•• Life sciences | unattributed | 1 | at least $13.8M | 101c | n/a | May 15, 2027 | Jun 30, 2026 |
| W••• D••••••••• M••••••••• H•••••••• L•• Healthcare services | unattributed | 2 | at least $13.8M | 97c | n/a | Mar 17, 2028 | Dec 31, 2021 |
| P••••••••• I••••••••• L• Life sciences | H•••••• I••••••••• M••••••••• L••••• inferred | 3 | at least $13.6M | 101c | n/a | Sep 30, 2027 | Dec 31, 2022 |
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.